Cargando…
The Use of Tricyclo-DNA Oligomers for the Treatment of Genetic Disorders
Antisense Oligonucleotides (ASOs) represent very attractive therapeutic compounds for the treatment of numerous diseases. The antisense field has remarkably progressed over the last few years with the approval of the first antisense drugs and with promising developments of more potent and nuclease r...
Autores principales: | Aupy, Philippine, Echevarría, Lucía, Relizani, Karima, Goyenvalle, Aurélie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5874659/ https://www.ncbi.nlm.nih.gov/pubmed/29271929 http://dx.doi.org/10.3390/biomedicines6010002 |
Ejemplares similares
-
Palmitic acid conjugation enhances potency of tricyclo-DNA splice switching
oligonucleotides
por: Relizani, Karima, et al.
Publicado: (2021) -
Efficacy and Safety Profile of Tricyclo-DNA Antisense Oligonucleotides in Duchenne Muscular Dystrophy Mouse Model
por: Relizani, Karima, et al.
Publicado: (2017) -
Identifying and Avoiding tcDNA-ASO Sequence-Specific Toxicity for the Development of DMD Exon 51 Skipping Therapy
por: Aupy, Philippine, et al.
Publicado: (2019) -
Therapeutic Potential of Tricyclo-DNA antisense oligonucleotides
por: Goyenvalle, Aurelie, et al.
Publicado: (2016) -
Efficient SMN Rescue following Subcutaneous Tricyclo-DNA Antisense Oligonucleotide Treatment
por: Robin, Valérie, et al.
Publicado: (2017)